Navigation

Skiplink Navigation

Main Features

Novartis moves in closer on US eye-care group

Swiss pharmaceutical giant Novartis has confirmed moves to buy a majority stake in eye-care company Alcon with a view to gaining full ownership.

The Basel-based group said it would complete purchase of food and drinks company Nestlé's 52 per cent stake and then intended to buy the remaining 23 per cent stake from minority shareholders.

The group said in a statement on Monday that the entire cost of purchasing Nestlé's 77 per cent stake in Alcon shares would be $38.5 billion (SFr39.6 billion).

Novartis bought 25 per cent of Switzerland's Nestlé's Alcon stake for $10 billion in 2008, agreeing then to buy the group's remaining majority stake for $28 billion.

Alcon has its United States headquarters in Fort Worth, Texas, and employs around 15,000 people worldwide. When combined with Novartis, their portfolios would cover 70 per cent of the eye care sector.

swissinfo.ch and agencies


Links

Neuer Inhalt

Horizontal Line


subscription form

Form for signing up for free newsletter.

Sign up for our free newsletters and get the top stories delivered to your inbox.







Click here to see more newsletters

swissinfo EN

The following content is sourced from external partners. We cannot guarantee that it is suitable for the visually or hearing impaired.

Join us on Facebook!

×